MICHAEL WHITE to Gene Expression Regulation, Neoplastic
This is a "connection" page, showing publications MICHAEL WHITE has written about Gene Expression Regulation, Neoplastic.
Connection Strength
0.399
-
The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategies. Nat Commun. 2017 02 16; 8:14356.
Score: 0.075
-
A genome-scale screen reveals context-dependent ovarian cancer sensitivity to miRNA overexpression. Mol Syst Biol. 2015 Dec 11; 11(12):842.
Score: 0.069
-
Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non-Small Cell Lung Cancer and Its Potential as a Circulating Biomarker. Cancer Prev Res (Phila). 2016 Jan; 9(1):43-52.
Score: 0.068
-
A 12-gene set predicts survival benefits from adjuvant chemotherapy in non-small cell lung cancer patients. Clin Cancer Res. 2013 Mar 15; 19(6):1577-86.
Score: 0.057
-
A multilineage screen identifies actionable synthetic lethal interactions in human cancers. Nat Genet. 2025 Jan; 57(1):154-164.
Score: 0.032
-
An in vivo functional genomics screen of nuclear receptors and their co-regulators identifies FOXA1 as an essential gene in lung tumorigenesis. Neoplasia. 2020 08; 22(8):294-310.
Score: 0.023
-
Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells. Mol Cell. 2019 12 05; 76(5):838-851.e5.
Score: 0.022
-
SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers. Nat Commun. 2017 01 19; 8:14098.
Score: 0.019
-
Computational discovery of pathway-level genetic vulnerabilities in non-small-cell lung cancer. Bioinformatics. 2016 05 01; 32(9):1373-9.
Score: 0.017
-
Genetic mutation of p53 and suppression of the miR-17~92 cluster are synthetic lethal in non-small cell lung cancer due to upregulation of vitamin D Signaling. Cancer Res. 2015 Feb 15; 75(4):666-75.
Score: 0.016